正大企業國際：2025中期報告.pdf

1、INTERIM REPORT 2025 中期報告CHIA TAI ENTERPRISES INTERNATIONAL LIMITED 正 大 企 業 國 際 有 限 公 司Incorporated in Bermuda with members limited liability Stock Code:3839於 百 慕 達 註 冊 成 立 之 成 員 有 限 責 任 公 司 股 份 代 號：383901IN T ERIM REP OR T 2025二 零 二 五 年 中 期 報 告正 大 企 業 國 際 有 限 公 司 CHIA TAI ENTERPRISES INTERNATIONAL L

2、IMITED2Management Discussion and Analysis管理層討論及分析6Report on Review of Interim Financial Report中期財務報告之審閱報告8Consolidated Statement of Comprehensive Income綜合全面收益表10Consolidated Statement of Financial Position綜合財務狀況表12Consolidated Statement of Changes in Equity綜合權益變動表14Condensed Consolidated Statement o

3、f Cash Flows簡明綜合現金流量表15Notes to Interim Financial Report中期財務報告附註31Other Information其他資料35Corporate Information公司資料 Contents目 錄02正 大 企 業 國 際 有 限 公 司 CHIA TAI ENTERPRISES INTERNATIONAL LIMITEDIN T ERIM REP OR T 2025二 零 二 五 年 中 期 報 告GROUP RESULTSThe Group has two lines of business:biochemical business

4、and industrial business.The biochemical business focuses on animal health products and chlortetracycline(“CTC”),and is carried on by Group subsidiaries.This business segment accounts for all of the Groups consolidated revenue.The industrial business comprises the Groups interests in its joint ventur

5、e ECI Metro Investment Co.,Ltd.(together with its subsidiaries,“ECI Metro”)and its associate Zhanjiang Deni Vehicle Parts Co.,Ltd.(together with its subsidiaries,“Zhanjiang Deni”).The results of the Groups industrial business are incorporated in the consolidated statement of comprehensive income as

6、share of profits and losses of joint venture and associate.For the six months ended 30 June 2025(“1H2025”),the Groups revenue increased by approximately two times to US$323.3 million(for the six months ended 30 June 2024(“1H2024”):US$108.0 million).As mentioned above,the Groups revenue came from its